Literature DB >> 24723276

Prevention of central line-associated bloodstream infections through quality improvement interventions: a systematic review and meta-analysis.

Koen Blot1, Jochen Bergs2, Dirk Vogelaers3, Stijn Blot4, Dominique Vandijck5.   

Abstract

This systematic review and meta-analysis examines the impact of quality improvement interventions on central line-associated bloodstream infections in adult intensive care units. Studies were identified through Medline and manual searches (1995-June 2012). Random-effects meta-analysis obtained pooled odds ratios (ORs) and 95% confidence intervals (CIs). Meta-regression assessed the impact of bundle/checklist interventions and high baseline rates on intervention effect. Forty-one before-after studies identified an infection rate decrease (OR, 0.39 [95% CI, .33-.46]; P < .001). This effect was more pronounced for trials implementing a bundle or checklist approach (P = .03). Furthermore, meta-analysis of 6 interrupted time series studies revealed an infection rate reduction 3 months postintervention (OR, 0.30 [95% CI, .10-.88]; P = .03). There was no difference in infection rates between studies with low or high baseline rates (P = .18). These results suggest that quality improvement interventions contribute to the prevention of central line-associated bloodstream infections. Implementation of care bundles and checklists appears to yield stronger risk reductions.
© The Author 2014. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

Keywords:  catheter-related bloodstream infection; central line–associated bloodstream infection; meta-analysis; quality improvement intervention

Mesh:

Year:  2014        PMID: 24723276      PMCID: PMC4305144          DOI: 10.1093/cid/ciu239

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  66 in total

1.  Preventing central venous catheter-related infection in a surgical intensive-care unit.

Authors:  R Bijma; A R Girbes; D J Kleijer; J H Zwaveling
Journal:  Infect Control Hosp Epidemiol       Date:  1999-09       Impact factor: 3.254

2.  Aiming for zero: decreasing central line associated bacteraemia in the intensive care unit.

Authors:  Mary E Seddon; Catherine J Hocking; Pat Mead; Catherine Simpson
Journal:  N Z Med J       Date:  2011-07-29

3.  Impact of an educational program and policy changes on decreasing catheter-associated bloodstream infections in a medical intensive care unit in Brazil.

Authors:  Renata D Lobo; Anna Sara Levin; Laura M Brasileiro Gomes; Rosa Cursino; Marcelo Park; Valquiria B Figueiredo; Leandro Taniguchi; Cilmara G Polido; Silvia Figueiredo Costa
Journal:  Am J Infect Control       Date:  2005-03       Impact factor: 2.918

4.  Using real time process measurements to reduce catheter related bloodstream infections in the intensive care unit.

Authors:  R J Wall; E W Ely; T A Elasy; R S Dittus; J Foss; K S Wilkerson; T Speroff
Journal:  Qual Saf Health Care       Date:  2005-08

5.  The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions.

Authors:  S H Downs; N Black
Journal:  J Epidemiol Community Health       Date:  1998-06       Impact factor: 3.710

6.  A quality improvement program combining maximal barrier precaution compliance monitoring and daily chlorhexidine gluconate baths resulting in decreased central line bloodstream infections.

Authors:  Antoinette C Lopez
Journal:  Dimens Crit Care Nurs       Date:  2011 Sep-Oct

7.  The effect of process control on the incidence of central venous catheter-associated bloodstream infections and mortality in intensive care units in Mexico.

Authors:  Francisco Higuera; Victor Daniel Rosenthal; Pablo Duarte; Javier Ruiz; Guillermo Franco; Nasia Safdar
Journal:  Crit Care Med       Date:  2005-09       Impact factor: 7.598

8.  Use of corporate Six Sigma performance-improvement strategies to reduce incidence of catheter-related bloodstream infections in a surgical ICU.

Authors:  Heidi L Frankel; William B Crede; Jeffrey E Topal; Sarah A Roumanis; Marie W Devlin; Andrea B Foley
Journal:  J Am Coll Surg       Date:  2005-09       Impact factor: 6.113

9.  The effect of an education program on the incidence of central venous catheter-associated bloodstream infection in a medical ICU.

Authors:  David K Warren; Jeanne E Zack; Jennie L Mayfield; Alexander Chen; Donna Prentice; Victoria J Fraser; Marin H Kollef
Journal:  Chest       Date:  2004-11       Impact factor: 9.410

10.  Clinical and economic outcomes in critically ill patients with nosocomial catheter-related bloodstream infections.

Authors:  Stijn I Blot; Pieter Depuydt; Lieven Annemans; Dominique Benoit; Eric Hoste; Jan J De Waele; Johan Decruyenaere; Dirk Vogelaers; Francis Colardyn; Koenraad H Vandewoude
Journal:  Clin Infect Dis       Date:  2005-10-25       Impact factor: 9.079

View more
  43 in total

1.  Eliminating Infections in the ICU: CLABSI.

Authors:  Asad Latif; Muhammad Sohail Halim; Peter J Pronovost
Journal:  Curr Infect Dis Rep       Date:  2015-07       Impact factor: 3.725

2.  Catheter-associated bloodstream infection rates: how low can you go?

Authors:  Stijn Blot; Garyphallia Poulakou; Jean-Francois Timsit
Journal:  Intensive Care Med       Date:  2019-05-14       Impact factor: 17.440

3.  Complete adherence to evidence-based quality-of-care indicators for Staphylococcus aureus bacteremia resulted in better prognosis.

Authors:  Miki Nagao; Masaki Yamamoto; Yasufumi Matsumura; Isao Yokota; Shunji Takakura; Satoshi Teramukai; Satoshi Ichiyama
Journal:  Infection       Date:  2016-10-05       Impact factor: 3.553

4.  What is new in infection prevention in critical care in 2014?

Authors:  George Dimopoulos; Marin Kollef; Stijn Blot
Journal:  Intensive Care Med       Date:  2014-05-13       Impact factor: 17.440

5.  What is new for the prevention of catheter-related bloodstream infections?

Authors:  Leonardo Lorente
Journal:  Ann Transl Med       Date:  2016-03

Review 6.  Infective endocarditis.

Authors:  Thomas L Holland; Larry M Baddour; Arnold S Bayer; Bruno Hoen; Jose M Miro; Vance G Fowler
Journal:  Nat Rev Dis Primers       Date:  2016-09-01       Impact factor: 52.329

7.  Health Care-Associated Infective Endocarditis: a Growing Entity that Can Be Prevented.

Authors:  Natividad Benito; Juan M Pericas; Mercè Gurguí; Carlos A Mestres; Francesc Marco; Asunción Moreno; Juan P Horcajada; José M Miró
Journal:  Curr Infect Dis Rep       Date:  2014-11       Impact factor: 3.725

Review 8.  A state of the art review on optimal practices to prevent, recognize, and manage complications associated with intravascular devices in the critically ill.

Authors:  Jean-François Timsit; Mark Rupp; Emilio Bouza; Vineet Chopra; Tarja Kärpänen; Kevin Laupland; Thiago Lisboa; Leonard Mermel; Olivier Mimoz; Jean-Jacques Parienti; Garyphalia Poulakou; Bertrand Souweine; Walter Zingg
Journal:  Intensive Care Med       Date:  2018-05-12       Impact factor: 17.440

9.  Magnet® Hospital Recognition Linked to Lower Central Line-Associated Bloodstream Infection Rates.

Authors:  Hilary Barnes; Jessica Rearden; Matthew D McHugh
Journal:  Res Nurs Health       Date:  2016-01-25       Impact factor: 2.228

10.  Prevention of hospital infections by intervention and training (PROHIBIT): results of a pan-European cluster-randomized multicentre study to reduce central venous catheter-related bloodstream infections.

Authors:  Tjallie van der Kooi; Hugo Sax; Didier Pittet; Jaap van Dissel; Birgit van Benthem; Bernhard Walder; Vanessa Cartier; Lauren Clack; Sabine de Greeff; Martin Wolkewitz; Stefanie Hieke; Hendriek Boshuizen; Jan van de Kassteele; Annemie Van den Abeele; Teck Wee Boo; Magda Diab-Elschahawi; Uga Dumpis; Camelia Ghita; Susan FitzGerald; Tatjana Lejko; Kris Leleu; Mercedes Palomar Martinez; Olga Paniara; Márta Patyi; Paweł Schab; Annibale Raglio; Emese Szilágyi; Mirosław Ziętkiewicz; Albert W Wu; Hajo Grundmann; Walter Zingg
Journal:  Intensive Care Med       Date:  2017-12-16       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.